Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...
From there, they estimated how common Parkinson’s disease is based on a slew of factors, including a person’s age and sex, from 2022 to 2050. The researchers estimated that the number of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results